288 related articles for article (PubMed ID: 18523740)
1. New antiarrhythmic drugs for atrial fibrillation: focus on dronedarone and vernakalant.
Camm AJ; Savelieva I
J Interv Card Electrophysiol; 2008 Oct; 23(1):7-14. PubMed ID: 18523740
[TBL] [Abstract][Full Text] [Related]
2. Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches.
Savelieva I; Camm J
Europace; 2008 Jun; 10(6):647-65. PubMed ID: 18515286
[TBL] [Abstract][Full Text] [Related]
3. New horizons in antiarrhythmic therapy: will novel agents overcome current deficits?
Conway E; Musco S; Kowey PR
Am J Cardiol; 2008 Sep; 102(6A):12H-19H. PubMed ID: 18790110
[TBL] [Abstract][Full Text] [Related]
4. [New antiarrhythmic drugs for treatment of atrial fibrillation].
Raatikainen MJ; Huikuri HV
Duodecim; 2010; 126(19):2255-62. PubMed ID: 21086684
[TBL] [Abstract][Full Text] [Related]
5. New anthyarrhythmic drugs for atrial fibrillation.
Matassini MV; Guerra F; Scappini L; Urbinati A; Capucci A
Future Cardiol; 2015; 11(6):705-17. PubMed ID: 26631497
[TBL] [Abstract][Full Text] [Related]
6. The pharmaceutical pipeline for atrial fibrillation.
Santangeli P; Di Biase L; Pelargonio G; Burkhardt JD; Natale A
Ann Med; 2011 Feb; 43(1):13-32. PubMed ID: 21166558
[TBL] [Abstract][Full Text] [Related]
7. New antiarrhythmic drugs for treatment of atrial fibrillation.
Dobrev D; Nattel S
Lancet; 2010 Apr; 375(9721):1212-23. PubMed ID: 20334907
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines.
Savelieva I; Graydon R; Camm AJ
Europace; 2014 Feb; 16(2):162-73. PubMed ID: 24108230
[TBL] [Abstract][Full Text] [Related]
9. [New antiarrhythmic drugs for the treatment of atrial fibrillation].
Botto GL; Russo G; Mariconti B; Pentimalli F; Campana C
G Ital Cardiol (Rome); 2012 Oct; 13(10 Suppl 2):10S-15S. PubMed ID: 23096368
[TBL] [Abstract][Full Text] [Related]
10. Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation.
Duggan ST; Scott LJ
Drugs; 2011 Jan; 71(2):237-52. PubMed ID: 21275448
[TBL] [Abstract][Full Text] [Related]
11. [New developments in the antiarrhythmic therapy of atrial fibrillation].
Simon H; Simon Demel K; Ritscher G; Turschner O; Brachmann J
Herzschrittmacherther Elektrophysiol; 2010 Dec; 21(4):212-6. PubMed ID: 21107985
[TBL] [Abstract][Full Text] [Related]
12. [Vernakalant--a new drug for pharmacological conversion of atrial fibrillation].
Hinneburg I
Med Monatsschr Pharm; 2011 May; 34(5):154-8. PubMed ID: 21644373
[TBL] [Abstract][Full Text] [Related]
13. Vernakalant: A novel agent for the termination of atrial fibrillation.
Finnin M
Am J Health Syst Pharm; 2010 Jul; 67(14):1157-64. PubMed ID: 20592320
[TBL] [Abstract][Full Text] [Related]
14. Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation.
Schweizer PA; Becker R; Katus HA; Thomas D
Drug Des Devel Ther; 2011 Jan; 5():27-39. PubMed ID: 21267357
[TBL] [Abstract][Full Text] [Related]
15. Vernakalant: pharmacology electrophysiology, safety and efficacy.
Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Stevenson R; Gonzalez MD
Drugs Today (Barc); 2008 May; 44(5):325-9. PubMed ID: 18548135
[TBL] [Abstract][Full Text] [Related]
16. A new antiarrhythmic drug in the treatment of recent-onset atrial fibrillation: vernakalant.
Vizzardi E; Salghetti F; Bonadei I; Gelsomino S; Lorusso R; D'Aloia A; Curnis A
Cardiovasc Ther; 2013 Oct; 31(5):e55-62. PubMed ID: 23398692
[TBL] [Abstract][Full Text] [Related]
17. Novel approaches for pharmacological management of atrial fibrillation.
Ehrlich JR; Nattel S
Drugs; 2009; 69(7):757-74. PubMed ID: 19441867
[TBL] [Abstract][Full Text] [Related]
18. [Vernakalant: a novel antiarrhythmic drug for the rapid conversion of atrial fibrillation to sinus rhythm].
Hirt MN; Eschenhagen T
Dtsch Med Wochenschr; 2010 May; 135(19):971-6. PubMed ID: 20446233
[TBL] [Abstract][Full Text] [Related]
19. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.
Singh BN
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):31S-5S. PubMed ID: 21098417
[TBL] [Abstract][Full Text] [Related]
20. Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?
Ehrlich JR; Nattel S
Curr Opin Cardiol; 2009 Jan; 24(1):50-5. PubMed ID: 19077816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
